Prevention of Hepatitis B recurrence following liver transplantation
HepaGam B™, Hepatitis B Immune Globulin Intravenous (Human), is indicated
for the prevention of hepatitis B recurrence following liver transplantation,
in HBsAg-positive liver transplant patients.
HepaGam B (hepatitis b immune globulin (human)) should be administered intravenously for this indication.
Postexposure Prophylaxis
HepaGam B (hepatitis b immune globulin (human)) is indicated for the treatment of acute exposure to blood containing HBsAg, perinatal exposure of in...
Read the complete drug monograph for HepaGam B »